Public Employees Retirement System of Ohio Makes New $1.87 Million Investment in Amedisys, Inc. (NASDAQ:AMED)

Public Employees Retirement System of Ohio purchased a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 20,590 shares of the health services provider's stock, valued at approximately $1,869,000. Public Employees Retirement System of Ohio owned approximately 0.06% of Amedisys as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Blue Trust Inc. lifted its position in Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares during the last quarter. Xponance Inc. grew its position in Amedisys by 3.5% during the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after acquiring an additional 148 shares during the last quarter. Gamco Investors INC. ET AL boosted its position in Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock valued at $2,754,000 after buying an additional 159 shares during the period. Retirement Systems of Alabama increased its holdings in shares of Amedisys by 0.5% in the fourth quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider's stock worth $3,615,000 after buying an additional 181 shares during the period. Finally, US Bancorp DE boosted its stake in shares of Amedisys by 5.7% during the fourth quarter. US Bancorp DE now owns 3,916 shares of the health services provider's stock valued at $356,000 after purchasing an additional 210 shares during the period. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Up 0.0%

AMED traded up $0.02 on Thursday, hitting $94.59. The company had a trading volume of 46,967 shares, compared to its average volume of 409,057. The stock has a fifty day moving average price of $93.59 and a 200-day moving average price of $91.66. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of 37.46, a P/E/G ratio of 1.78 and a beta of 0.96. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. During the same quarter last year, the company posted $1.03 earnings per share. The business's quarterly revenue was up 4.1% on a year-over-year basis. Analysts predict that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have commented on AMED shares. Wall Street Zen lowered Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research report on Wednesday, April 16th. Finally, Stephens restated an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.